CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease

Carmen Noelker; Vanessa Stuckenholz; Jens Peter Reese; Daniel Alvarez-Fischer; Roman Sankowski; Tanja Rausch; Wolfgang H. Oertel; Andreas Hartmann; Sonya Van Patten; Yousef Al-Abed; Michael Bacher

doi:10.1159/000342714

CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease

Carmen Noelker, Vanessa Stuckenholz, Jens Peter Reese, Daniel Alvarez-Fischer, Roman Sankowski, Tanja Rausch, Wolfgang H. Oertel, Andreas Hartmann, Sonya Van Patten, Yousef Al-Abed, Michael Bacher^*

^*Corresponding author for this work

Clinic of Psychiatry and Psychotherapy

7 Citations (Scopus)

Abstract

Background: Parkinson's disease (PD) is associated with neurodegeneration of dopaminergic neurons in the substantia nigra. Neuroinflammatory processes have been shown to be a key component of this neurodegeneration and, as such, small molecule compounds which inhibit these inflammatory events are a critical research focus.

Original language	English
Journal	Neurodegenerative Diseases
Volume	12
Issue number	2
Pages (from-to)	103-110
Number of pages	8
ISSN	1660-2854
DOIs	https://doi.org/10.1159/000342714
Publication status	Published - 2013

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000342714

Cite this

Noelker, C., Stuckenholz, V., Reese, J. P., Alvarez-Fischer, D., Sankowski, R., Rausch, T., Oertel, W. H., Hartmann, A., Van Patten, S., Al-Abed, Y., & Bacher, M. (2013). CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease. Neurodegenerative Diseases, 12(2), 103-110. https://doi.org/10.1159/000342714

@article{39aa382a1ad44fc2b62dbb9bb89f5eaf,

title = "CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease",

abstract = "Background: Parkinson's disease (PD) is associated with neurodegeneration of dopaminergic neurons in the substantia nigra. Neuroinflammatory processes have been shown to be a key component of this neurodegeneration and, as such, small molecule compounds which inhibit these inflammatory events are a critical research focus.",

author = "Carmen Noelker and Vanessa Stuckenholz and Reese, {Jens Peter} and Daniel Alvarez-Fischer and Roman Sankowski and Tanja Rausch and Oertel, {Wolfgang H.} and Andreas Hartmann and {Van Patten}, Sonya and Yousef Al-Abed and Michael Bacher",

note = "Publisher Copyright: Copyright {\textcopyright} 2012 S. Karger AG, Basel.",

year = "2013",

doi = "10.1159/000342714",

language = "English",

volume = "12",

pages = "103--110",

journal = "Neurodegenerative Diseases",

issn = "1660-2854",

number = "2",

}

Noelker, C, Stuckenholz, V, Reese, JP, Alvarez-Fischer, D, Sankowski, R, Rausch, T, Oertel, WH, Hartmann, A, Van Patten, S, Al-Abed, Y & Bacher, M 2013, 'CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease', Neurodegenerative Diseases, vol. 12, no. 2, pp. 103-110. https://doi.org/10.1159/000342714

TY - JOUR

T1 - CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease

AU - Noelker, Carmen

AU - Stuckenholz, Vanessa

AU - Reese, Jens Peter

AU - Alvarez-Fischer, Daniel

AU - Sankowski, Roman

AU - Rausch, Tanja

AU - Oertel, Wolfgang H.

AU - Hartmann, Andreas

AU - Van Patten, Sonya

AU - Al-Abed, Yousef

AU - Bacher, Michael

PY - 2013

Y1 - 2013

N2 - Background: Parkinson's disease (PD) is associated with neurodegeneration of dopaminergic neurons in the substantia nigra. Neuroinflammatory processes have been shown to be a key component of this neurodegeneration and, as such, small molecule compounds which inhibit these inflammatory events are a critical research focus.

AB - Background: Parkinson's disease (PD) is associated with neurodegeneration of dopaminergic neurons in the substantia nigra. Neuroinflammatory processes have been shown to be a key component of this neurodegeneration and, as such, small molecule compounds which inhibit these inflammatory events are a critical research focus.

UR - http://www.scopus.com/inward/record.url?scp=84881175042&partnerID=8YFLogxK

U2 - 10.1159/000342714

DO - 10.1159/000342714

M3 - Journal articles

C2 - 23147695

AN - SCOPUS:84881175042

SN - 1660-2854

VL - 12

SP - 103

EP - 110

JO - Neurodegenerative Diseases

JF - Neurodegenerative Diseases

IS - 2

ER -

CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease

Abstract

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this